Panacea Biotec Ltd.
PANACEABIO Share PricePharmaceuticals & Drugs
₹347.2
-3.2 (-0.9%)
As on December 4, 2025
Exchange Scrips: BSE531349NSEPANACEABIOISININE922B01023
Market Cap ₹ 2,131 Cr
P/E Ratio -254.08
Dividend Yield N/A
Performance
Market performance
Open350.35
High351.7
Volumes74,720
Prev347.2
Low343
As on2025-12-04
Historical performance
1 Year High581.9
3 Year High581.9
5 Year High581.9
1 Year Low281.1
3 Year Low107
5 Year Low107
Fundamentals
Company Valuation
Market Cap (₹Cr)
2,131
Face Value (₹)
1
P/E Ratio
-254.08
Dividend Yield
N/A
Investment Returns
1 Year
-22.8%
3 Years
145.8%
5 Years
62.1%
10 Years
126.2%
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 356.37 | Bearish |
| 10-DMA | 357.05 | Bearish |
| 20-DMA | 374.36 | Bearish |
| 50-DMA | 407.79 | Bearish |
| 100-DMA | 412.99 | Bearish |
| 200-DMA | 428.94 | Bearish |
Shareholding Pattern
| Field | Sep-2025 | Jun-2025 | Mar-2025 | Dec-2024 | Sep-2024 |
|---|---|---|---|---|---|
| Promoters | 6 | 6 | 6 | 6 | 6 |
| Foreign Investors | --- | --- | --- | --- | --- |
| Domestic Investors | 6 | 6 | 6 | 6 | 6 |
| Public Investors | 33587 | 34250 | 33587 | 35440 | 39976 |
| Government | --- | --- | --- | --- | --- |
Financials
Below figures are in Rs. Crores
Balance Sheet
Below figures are in Rs. Crores
Cash Flow
Below figures are in Rs. Crores
0%
Negative
Neutral
Positive
- The stock has a PE ratio of -254.08.
- 3Y Stock Price CAGR of the stock is 34.5.
- The stock has a beta of 1.1.
- In the last financial year, the company had an EBITDA of ₹-53 Million.
- The company generated revenue of ₹5591 Million in the previous financial year.
Panacea Biotec Ltd.
347.2-3.2 (-0.9%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 768907.1
No. of Shares: 2215 (Approx)
Performance:-23.1%
P/L: ₹-231092.9
Top Gainers
Peer Comparison
Get Your Portfolio Reviewed
